Charles Zhu Stock Analyst Profile - LifeSci Capital Research Coverage - Stocknear

Charles Zhu

Stock Analyst at LifeSci Capital

(4.7)
# 1056
Out of 5,493 analysts
27
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

12 Stocks

Name Action PT Current % Upside Ratings Updated
CBIO Crescent Biopharma
Initiates Coverage On: Outperform
22
n/a n/a 1 Jun 18, 2025
RPTX Repare Therapeutics
Downgrades: Market Perform
n/a
n/a n/a 1 Dec 13, 2024
TNGX Tango Therapeutics
Maintains: Buy
18 8
8.53 -6.21% 3 Nov 7, 2024
MGNX Macrogenics
Upgrades: Buy
12
1.73 593.64% 4 Nov 7, 2023
MRUS Merus
Maintains: Strong Buy
46 48
68.89 -30.32% 6 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
56
81.39 -31.2% 1 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
22
4.25 417.65% 1 Jul 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
26
14.16 83.62% 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32
26.83 19.27% 3 Mar 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
14
16.6 -15.66% 2 May 5, 2022